CUA Educational Content

Empowering Radioligand Therapy for mCRPC: Translating clinical evidence and real-world insights into practical strategies for mCRPC management

Speakers: Aly-Khan Lalani, Frédéric Pouliot & Hayley Roberts

Objectives

By the end of this program, participants can expect to:

  • Review recent RLT clinical and real-world results in mCRPC
  • Summarize the differences between clinical trials and real-world data, focusing on a patient-centric approach to treatment
  • Share recent experiences of implementing an RLT centre 
Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.

-------------------------------------

This program has received financial support from Novartis in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy